期刊
AGING-US
卷 9, 期 4, 页码 1341-1350出版社
IMPACT JOURNALS LLC
DOI: 10.18632/aging.101231
关键词
Leber's hereditary optic neuropathy; disease model; induced pluripotent stem cells; retinal ganglion cells; cybrid
资金
- National Health and Medical Research Council (NHMRC) [1084256]
- Australian Mitochondrial Disease Foundation
- Brockhoff foundation
- University of Melbourne
- Ophthalmic Research Institute of Australia
- NHMRC Practitioner Fellowship [APP1103329]
- Australian Research Council Future Fellowship [FT140100047]
- Peggy and Leslie Cranbourne Foundation Fellowship
- Medical Advances Without Animals Trust Fellowship
- Victorian Government
- National Health and Medical Research Council of Australia [1084256] Funding Source: NHMRC
Cybrid technology was used to replace Leber hereditary optic neuropathy (LHON) causing mitochondrial DNA (mtDNA) mutations from patient-specific fibroblasts with wildtype mtDNA, and mutation-free induced pluripotent stem cells (iPSCs) were generated subsequently. Retinal ganglion cell (RGC) differentiation demonstrates increased cell death in LHON-RGCs and can be rescued in cybrid corrected RGCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
